Tretinoin works.
It also tests your patience.

Tretinoin is all-trans retinoic acid, the active form of vitamin A that binds directly to retinoic acid receptors in the cell nucleus. This direct binding is what distinguishes tretinoin from over-the-counter retinol, which has to be converted through several enzymatic steps before it can act on those receptors. The conversion is inefficient, roughly 1% of applied retinol reaches the active form, which is why retinol products require concentrations 10 to 100 times higher than tretinoin to produce comparable effects, and why tretinoin works on a much faster timeline.

Once tretinoin reaches the receptor, it normalizes the lifecycle of keratinocytes (the cells lining the follicle). In acne-prone skin, those keratinocytes shed too slowly and clump together, creating the keratin plugs that become comedones. Tretinoin accelerates and normalizes that turnover, which prevents new comedones from forming in the first place. This is fundamentally different from how salicylic acid or benzoyl peroxide works, those treat existing lesions; tretinoin prevents the next ones.

The downstream effect on collagen is what makes tretinoin notable beyond acne. Long-term tretinoin use thickens the dermis, increases collagen production, and softens fine lines and post-acne textural changes. This is why patients in their thirties and forties often continue tretinoin after their acne resolves, it is the only acne medication with a substantial body of evidence for long-term skin quality outcomes, with documentation going back to the 1986 Photoaging study by Kligman.

The retinization period, roughly weeks one through twelve of tretinoin, is the single most important thing to understand before starting. Skin response follows a predictable pattern: weeks one to four are characterized by dryness, fine flaking, and increasing redness, especially around the mouth and nose where skin is thinnest. Weeks four to eight typically feature the "tretinoin purge", a temporary worsening of acne as deep comedones surface and clear. Weeks eight to twelve are when the skin begins to adapt, the irritation subsides, and visible improvement starts to appear.

The purge is real, well-documented, and the most common reason patients abandon tretinoin. It is not a sign that the treatment is failing, it is the predictable consequence of an accelerated keratinocyte turnover bringing existing subclinical comedones to the surface faster than they would have otherwise. A 2008 review in Skin Therapy Letter noted that 25% to 35% of new tretinoin patients experience a measurable acne flare in weeks two to six, with resolution by week ten in most cases. Knowing this is coming is the difference between persistence and abandonment.

The other practical reality is that tretinoin and a damaged barrier do not coexist. The reason starting concentration matters so much is that 0.025% applied to intact skin is well-tolerated for most people, while 0.05% or 0.1% applied to skin already irritated by acid use, harsh cleansing, or recent waxing produces severe inflammation. The "sandwich method", moisturizer, then a pea-sized amount of tretinoin, then more moisturizer, and "short contact" use (applied for 20 minutes, then washed off) are evidence-backed strategies for getting through retinization without abandoning the medication.

Tretinoin is available in 0.025%, 0.05%, and 0.1% concentrations in cream and gel formulations, with newer microsphere and lotion formulations spanning similar ranges. The clinically supported approach for almost everyone starting tretinoin is to begin at 0.025% cream, which is gentler than gel and tolerates the addition of moisturizers more readily. Going straight to 0.05% or 0.1% is the most common cause of severe retinization that ends a tretinoin trial in the first month.

Once 0.025% has been tolerated for at least three to four months, an increase to 0.05% is reasonable if results have plateaued. The marginal benefit of moving from 0.05% to 0.1% is smaller than the marginal cost in irritation, and many dermatologists do not recommend it for routine acne use. The exceptions are patients with significant comedonal load that has not responded to 0.05% after six months of consistent use.

Cream versus gel matters more than most people realize. Gel formulations dry faster, are typically more potent in their delivery, and are less forgiving on dehydrated skin. Cream formulations spread more easily, allow simultaneous moisturizer use, and are the better choice for almost anyone in their first six months on tretinoin or for anyone with combination or dry skin. Switching from cream to gel later, once skin has acclimated, is a reasonable progression. Starting at gel is not.

Tretinoin's clinical timeline is what makes tracking essential. The skin gets visibly worse before it gets better, and by week six most patients have no objective sense of whether they are on the trajectory the trials predict or whether the medication is failing them. Without a daily log to compare week one to week six, the brain anchors to the worst day in the past three weeks and concludes the medication is making things worse.

The right approach is two weeks of pre-treatment baseline followed by twelve to twenty-four weeks of structured logging, daily severity score, lesion count if you can manage it, notes on dryness and peeling, and which other products you used. Weekly photos under consistent lighting are the single most useful adjunct, because the brain underweights gradual change in a way photos do not. Most patients who keep this kind of log become much more willing to push through retinization because the data shows them they are tracking on the expected curve.

The signals that tretinoin is not the right tool for you are different from the signals that you are still in retinization. Persistent severe inflammation past week sixteen, no reduction in comedonal density at week twenty, or signs of perioral dermatitis (a specific irritation pattern around the mouth) all warrant a dermatologist re-evaluation. Continued cyclical hormonal breakouts on the jawline at month four suggest you also need a hormonal intervention, since tretinoin works on the follicle but not on the underlying sebum drive in androgen-sensitive skin. ClearSkin's pattern analysis is built specifically to surface this kind of signal in your own data.